Truist Financial
LMAT icon

Truist Financial’s LeMaitre Vascular LMAT Stock Holding History

Truist Financial’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$477K Buy
4,968
+968
+24% +$99.2K ﹤0.01% 2231
2026
Q1 		$437K Buy
+4,000
New +$381K ﹤0.01% 2145
2025
Q3 		– Sell
-6,952
Closed -$577K – 2759
2025
Q2 		$577K Buy
6,952
+43
+0.6% +$3.59K ﹤0.01% 1892
2025
Q1 		$580K Sell
6,909
-2,014
-23% -$187K ﹤0.01% 1788
2024
Q4 		$822K Buy
8,923
+1,547
+21% +$149K ﹤0.01% 1638
2024
Q3 		$685K Buy
7,376
+322
+5% +$27.9K ﹤0.01% 1705
2024
Q2 		$580K Buy
7,054
+3,381
+92% +$248K ﹤0.01% 1881
2024
Q1 		$244K Sell
3,673
-415
-10% -$25.6K ﹤0.01% 2396
2023
Q4 		$232K Buy
4,088
+91
+2% +$4.77K ﹤0.01% 2441
2023
Q3 		$218K Buy
3,997
+210
+6% +$12.4K ﹤0.01% 2421
2023
Q2 		$255K Sell
3,787
-361
-9% -$22K ﹤0.01% 2334
2023
Q1 		$213K Buy
+4,148
New +$201K ﹤0.01% 2397
2022
Q4 		– Sell
-4,237
Closed -$215K – 2642
2022
Q3 		$215K Buy
+4,237
New +$212K ﹤0.01% 2268
2020
Q1 		– Sell
-5,922
Closed -$213K – 2502
2019
Q4 		$213K Buy
+5,922
New +$204K ﹤0.01% 2326
2019
Q2 		– Sell
-6,564
Closed -$203K – 783
2019
Q1 		$203K Buy
+6,564
New +$175K ﹤0.01% 733
2018
Q4 		– Sell
-5,889
Closed -$228K – 773
2018
Q3 		$228K Sell
5,889
-340
-5% -$12.3K ﹤0.01% 728
2018
Q2 		$209K Sell
6,229
-275
-4% -$9.78K ﹤0.01% 725
2018
Q1 		$236K Buy
6,504
+165
+3% +$5.71K ﹤0.01% 703
2017
Q4 		$202K Buy
+6,339
New +$217K ﹤0.01% 762

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Truist Financial's LMAT Position: Q2 2026 in Review

Truist Financial increased its LeMaitre Vascular (LMAT) stake by 24% in Q2 2026, buying an estimated $99.2K and bringing the position to 4,968 shares worth $477K. The position accounts for ﹤0.01% of the portfolio, ranked #2231.

Truist Financial first reported a position in LMAT in Q4 2017 and has held it in 19 quarters since. The position peaked at $822K in Q4 2024. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Truist Financial held 4,968 shares of LeMaitre Vascular worth $477K as of Q2 2026.
  • Truist Financial bought 968 LeMaitre Vascular shares in Q2 2026, an estimated $99.2K.
  • LeMaitre Vascular made up ﹤0.01% of Truist Financial's portfolio in Q2 2026, its #2231 holding.
  • Truist Financial first reported a position in LeMaitre Vascular in Q4 2017 and has held it in 19 quarters since.
  • Truist Financial's LeMaitre Vascular position peaked at $822K in Q4 2024.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.